Regulators Stand Up for Biosimilars

Development of biosimilars has expanded patients’ treatment options by offering innovative medicine at lower costs than traditional biologics. So why are some nations slow to adopt biosimilars?

Can Health Research Survive Brexit?

The United Kingdom’s Brexit saga has captured the attention of the world.  But it’s also sparked concerns among British patients, researchers and health care advocates, who are asking: How will health research and innovation fare after the UK severs ties with the European Union? Research on cardiovascular disease provides an apt example.  According to the […]

Survey Highlights Desire for Innovation in Latin America

Central and South American governments should consider new policies that support innovation in health care and improve patient access, according to results from a survey recently conducted by the Global Alliance for Patient Access.

Encuesta destaca el deseo de impulsar innovación en América Latina

Según los resultados de una encuesta realizada recientemente por la Alianza Global para el Acceso de Pacientes, los gobiernos de América Central y América del Sur deben considerar nuevas políticas que apoyen la innovación en la atención médica y mejoren el acceso a los pacientes.